Barbara C van Munster is an expert in Geriatrics at University Medical Center Groningen (Netherlands). As of October 2026, ScienceLeadR ranks Barbara C van Munster in the top 1% of experts worldwide for Cognition Disorders and Neurocognitive Disorders. Barbara C van Munster has authored 303 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 980 (community average: 125). How the SLR is computed.

LeadR Profile

Barbara C van Munster University Medical Center Groningen Netherlands
980 ScienceLeadR Reputation 980
Network Map

Geriatrics

Subspecialties: Neurology - Public Health - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

University Medical Center Groningen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 303

Citations

Citations: 8 845 1st author: 26 Last author: 79 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparing three approaches to delirium identification in older patients presenting to the emergency department.
PMID 42832155 — delirium, emergencies, risk assessment, geriatrics, emergency service, hospital
Eur Geriatr Med20260
The Relationship Between Social Cognition and Social Behavior in Patients with a Neurodegenerative Disease: A Systematic Review and Meta-Analysis.
PMID 42678610 — neuropsychology, social behavior, emotions, caregivers, signs and symptoms, social cognition, nervous system diseases, neurodegenerative diseases, cognition
Neuropsychol Rev20260
"Highlights of latest EAMA": generation research outputs of the 30-year anniversary cohort.
PMID 42406263 — research, geriatrics
Eur Geriatr Med20260
Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study.
PMID 42297456 — acyclovir, incidence, valacyclovir, alzheimer disease, pharmaceutical preparations, cohort studies, prescriptions, famciclovir, therapeutics
BMJ Open20261
Exploring the repurposing potential of β 2-adrenergic receptor agonists for cognitive function: Evidence from the PharmLines Initiative Retrospective Cohort Study.
PMID 42261707 — adrenergic agents, alzheimer disease, adrenergic agonists, cohort studies, receptors, adrenergic, pharmacoepidemiology, memory, cognition
J Alzheimers Dis20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 5
Phase 4 2

By status:

Completed 3
Active not recruiting 1
Not yet recruiting 1
Recruiting 1
Terminated 1

By type:

Observational 5
Interventional 2

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
YOD RiSoCo Social Cognition and Risk taking Behaviour in Patients with Young onset Dementia
NCT06286293 — dementia, risk-taking, social cognition, cognition
N/ANot yet recruiting2025

LeadR Networks

Main global connection map